TY - JOUR
T1 - Development of an extension of the OMERACT Summary of Measurement Properties table to capture equity considerations: SOMP-Equity.
AU - Humphreys, Jennifer
N1 - Funding Information:
We acknowledge the Equity Working Group members and the participants of the Equity Special Interest Group session: Adewale O Adebajo, Maria Agliotis, Jennifer Barton, Annelies Boonen, Peter Brooks, Rachelle Buchbinder, Flo Callahan, Willemina Campbell, Loreto Carmona, Robin Christensen, Maarten de Wit, Jonathan Epstein, Vicki Evans, Caroline Flurey, Niti Goel, Charlie Goldsmith, Susan Goodman, Rebecca Grainger, Francis Guillemin, Shawna Grosskleg, Glen Hazlewood, Catherine Hill, Ihsane Hmamouchi, Diana Hollander, Allyson Jones, Janet Jull, Kristin Kelley, Marios Kouloumas, Diane Lacaille, Alex Lee, Anne Lyddiatt, Sabrina Mai Neilsen, Win Min Oo, Jordi Pardo Pardo, Merce Pineros Vegas, Christoph Pohl, Tamara Rader, Sofia Ramiro, Oscar Russell, Nancy Santesso, Grayson Schultz, Jasvinder Singh, Antoine Sreih, Stephanie Taylor, Karine Toupin-April, Courage Uhunmwangho, Vivian Welch, Tiffany Westrich-Robertson.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/9/27
Y1 - 2021/9/27
N2 - Objective: To develop an equity extension of the OMERACT Summary of Measurement Properties (SOMP) Table, SOMP Equity to describe whether a patient reported outcome measure (PROM) works well among patients of diverse languages and cultures, education levels, and other population characteristics. Methods: We used the PROGRESS-Plus framework to categorize equity characteristics assessed in trials of PROM. PROGRESS refers to Place of residence, Race/ethnicity/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, and Social Capital, while the 'plus' captures additional characteristics, such as age. We pilot tested our SOMP Equity Extension using the Health Assessment Questionnaire (HAQ) as a prototypical PROM. Results: The SOMP Equity Extension retains the same columns as the original OMERACT SOMP (domain match, feasibility, construct validity, test-retest reliability, longitudinal construct validity, clinical trial discrimination, thresholds of meaning) but uses the PROGRESS-Plus characteristics as rows. We found several examples of studies of the HAQ which had assessed one or more PROGRESS-Plus characteristics. Conclusions: The most commonly reported equity considerations were related to language. OMERACT Equity virtual meeting participants were polled and they indicated that the SOMP Equity Extension is useful for highlighting and tracking equity considerations for OMERACT Core Outcome Measurement Instruments.
AB - Objective: To develop an equity extension of the OMERACT Summary of Measurement Properties (SOMP) Table, SOMP Equity to describe whether a patient reported outcome measure (PROM) works well among patients of diverse languages and cultures, education levels, and other population characteristics. Methods: We used the PROGRESS-Plus framework to categorize equity characteristics assessed in trials of PROM. PROGRESS refers to Place of residence, Race/ethnicity/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, and Social Capital, while the 'plus' captures additional characteristics, such as age. We pilot tested our SOMP Equity Extension using the Health Assessment Questionnaire (HAQ) as a prototypical PROM. Results: The SOMP Equity Extension retains the same columns as the original OMERACT SOMP (domain match, feasibility, construct validity, test-retest reliability, longitudinal construct validity, clinical trial discrimination, thresholds of meaning) but uses the PROGRESS-Plus characteristics as rows. We found several examples of studies of the HAQ which had assessed one or more PROGRESS-Plus characteristics. Conclusions: The most commonly reported equity considerations were related to language. OMERACT Equity virtual meeting participants were polled and they indicated that the SOMP Equity Extension is useful for highlighting and tracking equity considerations for OMERACT Core Outcome Measurement Instruments.
KW - OMERACT
KW - Patient-reported outcome measures
KW - equity
KW - inequalities
KW - social determinants of health
U2 - 10.1016/j.semarthrit.2021.09.005
DO - 10.1016/j.semarthrit.2021.09.005
M3 - Article
C2 - 34625296
SN - 0049-0172
VL - 51
SP - 1300
EP - 1310
JO - Seminars in arthritis and rheumatism
JF - Seminars in arthritis and rheumatism
IS - 6
ER -